Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III single-arm study of triptorelin acetate microspheres in children with central precocious puberty
CTR20240796Phase 3Completed
- Sponsor
- Lijun Pharmaceutical
- Start
- Jul 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in central precocious puberty (CPP), sponsored by Lijun Pharmaceutical. Started Jul 2024; status: completed.
02
Drugs
triptorelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on CTR20240796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240796.